Tiejun Yin

Jiefang Avenue 1095
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Overexpression of ORAOV1 and its association with immunotherapy resistance in hepatocellular carcinoma.

Overexpression of ORAOV1 and its association with immunotherapy resistance in hepatocellular carcinoma.

Journal: PeerJ

Published: February 10, 2025

Bibliometric analysis of global research trends between gut microbiota and pancreatic cancer: from 2004 to 2023.

Bibliometric analysis of global research trends between gut microbiota and pancreatic cancer: from 2004 to 2023.

Journal: Frontiers in microbiology

Published: September 12, 2023

Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review.

Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review.

Journal: Frontiers in oncology

Published: September 11, 2023

WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells.

WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells.

Journal: Molecular and cellular biochemistry

Published: July 17, 2023

Prognosis of immunotherapy for non-small cell lung cancer with CDKN2A loss of function.

Prognosis of immunotherapy for non-small cell lung cancer with CDKN2A loss of function.

Journal: Journal of thoracic disease

Published: June 27, 2023

Adenocarcinoma transformed into squamous cell carcinoma in non-small cell lung cancer.

Adenocarcinoma transformed into squamous cell carcinoma in non-small cell lung cancer.

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: May 12, 2021

Sequential use of EGFR-tyrosine kinase inhibitors based upon EGFR mutation evolution achieves long-term control in a non-small cell lung cancer patient: a case report.

Sequential use of EGFR-tyrosine kinase inhibitors based upon EGFR mutation evolution achieves long-term control in a non-small cell lung cancer patient: a case report.

Journal: Annals of palliative medicine

Published: July 24, 2020

Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.

Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.

Journal: BMC cancer

Published: February 21, 2020

Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology.

Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology.

Journal: Oncology letters

Published: February 23, 2019

A 5-year follow-up of primary seminal vesicle adenocarcinoma: A case report.

A 5-year follow-up of primary seminal vesicle adenocarcinoma: A case report.

Journal: Medicine

Published: October 14, 2018

Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials.

Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials.

Journal: Clinical colorectal cancer

Published: November 19, 2015

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.

Journal: Oncotarget

Published: December 09, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026